Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−12.87 MUSD
519.07 KUSD
29.02 K
About Epigenomics AG
Sector
Industry
Headquarters
Berlin
Website
Employees (FY)
34
Founded
2000
ISIN
DE000A37FT41
FIGI
BBG000BLD0P8
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EPGNF is 0.50 USD — it has decreased by 23.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Epigenomics AG stocks are traded under the ticker EPGNF.
Epigenomics AG is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
EPGNF stock is 30.00% volatile and has beta coefficient of 1.82. Check out the list of the most volatile stocks — is Epigenomics AG there?
Yes, you can track Epigenomics AG financials in yearly and quarterly reports right on TradingView.
Today Epigenomics AG has the market capitalization of 59.89 K, it has increased by 0.80% over the last week.
No, EPGNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EPGNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Epigenomics AG stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 34.00 employees. See our rating of the largest employees — is Epigenomics AG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Epigenomics AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Epigenomics AG stock shows the strong sell signal. See more of Epigenomics AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.